Targeting PDZ Binding Kinase Is Anti-tumorigenic in Novel Preclinical Models of ACC

Adrenocortical carcinoma (ACC) is an aggressive orphan malignancy with less than 35% 5-year survival and 75% recurrence. Surgery remains the primary therapy and Mitotane, an adrenolytic, is the only FDA approved drug with wide range toxicities and poor tolerability. There are no targeted agents avai...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Endocr Relat Cancer
Autors principals: Kar, Adwitiya, Zhang, Yu, Yacob, Betelehem W., Saeed, Jordan, Tompkins, Kenneth D., Bagby, Stacey M., Pitts, Todd M., Somerset, Hilary, Leong, Stephen, Wierman, Margaret E., Kiseljak-Vassiliades, Katja
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6938568/
https://ncbi.nlm.nih.gov/pubmed/31325906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-19-0262
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars